O
OrbiMed’s PMV Pharmaceuticals PMVP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.86M | Hold |
6,475,291
| – | – | 0.17% | 70 |
|
2025
Q1 | $7.06M | Hold |
6,475,291
| – | – | 0.17% | 70 |
|
2024
Q4 | $9.78M | Hold |
6,475,291
| – | – | 0.2% | 70 |
|
2024
Q3 | $9.65M | Hold |
6,475,291
| – | – | 0.18% | 79 |
|
2024
Q2 | $10.5M | Hold |
6,475,291
| – | – | 0.21% | 73 |
|
2024
Q1 | $11M | Hold |
6,475,291
| – | – | 0.2% | 78 |
|
2023
Q4 | $20.1M | Sell |
6,475,291
-87,786
| -1% | -$272K | 0.4% | 62 |
|
2023
Q3 | $40.3M | Hold |
6,563,077
| – | – | 0.86% | 42 |
|
2023
Q2 | $41.1M | Hold |
6,563,077
| – | – | 0.74% | 48 |
|
2023
Q1 | $31.3M | Hold |
6,563,077
| – | – | 0.61% | 55 |
|
2022
Q4 | $57.1M | Hold |
6,563,077
| – | – | 1.09% | 35 |
|
2022
Q3 | $78.1K | Hold |
6,563,077
| – | – | 1.45% | 25 |
|
2022
Q2 | $93.5K | Sell |
6,563,077
-292,346
| -4% | -$4.17K | 1.69% | 23 |
|
2022
Q1 | $143M | Sell |
6,855,423
-475,000
| -6% | -$9.89M | 2.31% | 12 |
|
2021
Q4 | $169M | Hold |
7,330,423
| – | – | 2.18% | 8 |
|
2021
Q3 | $218M | Hold |
7,330,423
| – | – | 2.4% | 11 |
|
2021
Q2 | $250M | Hold |
7,330,423
| – | – | 2.53% | 9 |
|
2021
Q1 | $241M | Hold |
7,330,423
| – | – | 2.25% | 12 |
|
2020
Q4 | $451M | Hold |
7,330,423
| – | – | 3.95% | 3 |
|
2020
Q3 | $260M | Buy |
+7,330,423
| New | +$260M | 3.27% | 3 |
|